Edwards Lifesciences Corporation Deferred Revenue Recognized
Edwards Lifesciences Corporation (EW) reported Deferred Revenue Recognized of $7.20 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-12.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2024-02-12
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $1.10M.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for the quarter ending 2018-09-30 was $800.00K.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for the quarter ending 2018-06-30 was $700.00K.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for fiscal 2022 was $7.20M, a 1.37% decline from fiscal 2021.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for fiscal 2021 was $7.30M, a 15.87% increase from fiscal 2020.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for fiscal 2020 was $6.30M, a 14.55% increase from fiscal 2019.
- Edwards Lifesciences Corporation contract with customer, liability, revenue recognized for fiscal 2019 was $5.50M, a 89.66% increase from fiscal 2018.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.20M 10-K · filed 2024-02-12 | |||
| 2021-12-31 | $7.30M 10-K · filed 2023-02-13 | |||
| 2020-12-31 | $6.30M 10-K · filed 2022-02-14 | |||
| 2019-12-31 | $5.50M 10-K · filed 2021-02-12 | |||
| 2019-03-31 | $1.10M 10-Q · filed 2019-04-26 | |||
| 2018-12-31 | $2.90M 10-K · filed 2020-02-14 | |||
| 2018-09-30 | $800.00K 10-Q · filed 2018-10-26 | $2.10M 10-Q · filed 2018-10-26 | ||
| 2018-06-30 | $700.00K 10-Q · filed 2018-07-27 | $1.30M 10-Q · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |